共有 50 笔近期内部人交易记录记录，涉及 IDEAYA Biosciences, Inc. (IDYA), 包括 37 笔买入 和 10 笔卖出. 内部人买入总额为 $128.94M 内部人卖出总额为 $1.89M.
近期活跃的重要内部人包括 Stein Jeffrey, Beaupre Darrin, Hata Yujiro S. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — IDYA
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-02 |
Stein Jeffrey |
Director |
知情买入 |
50,000 |
$32.96 |
$1.65M |
54,281 |
| 2026-01-30 |
Beaupre Darrin |
Chief Medical Officer |
限制性股票授予 (RSU) |
175,000 |
$32.19 |
$5.63M |
175,000 |
| 2026-01-30 |
Hata Yujiro S |
President and CEO |
限制性股票授予 (RSU) |
600,000 |
$32.19 |
$19.31M |
600,000 |
| 2026-01-30 |
Snyder Douglas B. |
SVP, General Counsel |
限制性股票授予 (RSU) |
130,000 |
$32.19 |
$4.18M |
130,000 |
| 2026-01-30 |
White Michael Anthony |
Chief Scientific Officer |
限制性股票授予 (RSU) |
190,000 |
$32.19 |
$6.12M |
190,000 |
| 2026-01-30 |
Ruiz Briseno Andres |
See Remarks |
限制性股票授予 (RSU) |
80,000 |
$32.19 |
$2.58M |
80,000 |
| 2026-01-30 |
Dorman Stuart |
Chief Commercial Officer |
限制性股票授予 (RSU) |
155,000 |
$32.19 |
$4.99M |
155,000 |
| 2026-01-30 |
Bleharski Joshua |
Chief Financial Officer |
限制性股票授予 (RSU) |
170,000 |
$32.19 |
$5.47M |
170,000 |
| 2025-11-28 |
Snyder Douglas B. |
SVP, General Counsel |
限制性股票授予 (RSU) |
1,041 |
$16.91 |
$17.6K |
2,080 |
| 2025-11-28 |
Ruiz Briseno Andres |
See Remarks |
限制性股票授予 (RSU) |
1,253 |
$16.91 |
$21.18K |
26,466 |
| 2025-06-27 |
Bleharski Joshua |
Chief Financial Officer |
未知 |
250,000 |
$20.05 |
$5.01M |
- |
| 2025-06-24 |
Yarno Wendy L |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-06-24 |
Rosen Terry J |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-06-24 |
Stein Jeffrey |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-06-24 |
Mackey Catherine J |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-06-24 |
Morrison Scott W |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-06-24 |
Hampton Malcolm Garret |
Director |
限制性股票授予 (RSU) |
20,000 |
$21.78 |
$435.6K |
20,000 |
| 2025-05-30 |
Snyder Douglas B. |
SVP, General Counsel |
限制性股票授予 (RSU) |
1,039 |
$16.91 |
$17.57K |
1,039 |
| 2025-02-27 |
Beaupre Darrin |
Chief Medical Officer |
限制性股票授予 (RSU) |
185,000 |
$20.24 |
$3.74M |
185,000 |
| 2025-02-27 |
Hata Yujiro S |
President and CEO |
限制性股票授予 (RSU) |
600,000 |
$20.24 |
$12.14M |
600,000 |
| 2025-02-27 |
Snyder Douglas B. |
SVP, General Counsel |
限制性股票授予 (RSU) |
33,000 |
$20.24 |
$667.92K |
33,000 |
| 2025-02-27 |
White Michael Anthony |
Chief Scientific Officer |
限制性股票授予 (RSU) |
185,000 |
$20.24 |
$3.74M |
185,000 |
| 2025-02-27 |
Ruiz Briseno Andres |
See Remarks |
限制性股票授予 (RSU) |
75,000 |
$20.24 |
$1.52M |
75,000 |
| 2025-02-27 |
Dorman Stuart |
Chief Commercial Officer |
限制性股票授予 (RSU) |
15,000 |
$20.24 |
$303.6K |
15,000 |
| 2025-02-18 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
12,808 |
$19.52 |
$250.01K |
182,192 |
| 2024-12-11 |
Dorman Stuart |
Chief Commercial Officer |
未知 |
170,000 |
$27.45 |
$4.67M |
- |
| 2024-11-29 |
Ruiz Briseno Andres |
See Remarks |
限制性股票授予 (RSU) |
682 |
$23.26 |
$15.86K |
25,213 |
| 2024-09-26 |
Snyder Douglas B. |
SVP, General Counsel |
限制性股票授予 (RSU) |
140,000 |
$30.50 |
$4.27M |
140,000 |
| 2024-09-18 |
Snyder Douglas B. |
Officer |
未知 |
- |
- |
- |
- |
| 2024-06-27 |
Throne Jason |
Chief Legal Officer |
期权行权（卖出） |
47,060 |
$7.01 |
$329.89K |
1,360 |
| 2024-05-31 |
Yarno Wendy L |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Rosen Terry J |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Stein Jeffrey |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Kelley Susan L. |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Mackey Catherine J |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Morrison Scott W |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-31 |
Hampton Malcolm Garret |
Director |
限制性股票授予 (RSU) |
16,200 |
$36.55 |
$592.11K |
16,200 |
| 2024-05-29 |
White Michael Anthony |
Chief Scientific Officer |
知情卖出 |
851 |
$36.78 |
$31.3K |
- |
| 2024-05-16 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
34,433 |
$4.31 |
$148.41K |
49,454 |
| 2024-05-15 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
83,856 |
$4.31 |
$361.42K |
83,887 |
| 2024-05-14 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
56,711 |
$4.31 |
$244.42K |
167,743 |
| 2024-03-01 |
Beaupre Darrin |
Chief Medical Officer |
限制性股票授予 (RSU) |
160,000 |
$46.22 |
$7.4M |
160,000 |
| 2024-03-01 |
Hata Yujiro S |
President and CEO |
限制性股票授予 (RSU) |
480,000 |
$46.22 |
$22.19M |
480,000 |
| 2024-03-01 |
Throne Jason |
Chief Legal Officer |
限制性股票授予 (RSU) |
125,500 |
$46.22 |
$5.8M |
125,500 |
| 2024-03-01 |
White Michael Anthony |
Chief Scientific Officer |
限制性股票授予 (RSU) |
140,000 |
$46.22 |
$6.47M |
140,000 |
| 2024-03-01 |
Ruiz Briseno Andres |
See Remarks |
限制性股票授予 (RSU) |
85,000 |
$46.22 |
$3.93M |
85,000 |
| 2024-02-09 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
23,557 |
$4.31 |
$101.53K |
224,454 |
| 2024-02-09 |
Ruiz Briseno Andres |
See Remarks |
知情卖出 |
2,000 |
$46.02 |
$92.04K |
24,531 |
| 2024-02-08 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
75,815 |
$4.31 |
$326.76K |
248,011 |
| 2024-02-01 |
Hata Yujiro S |
President and CEO |
期权行权（卖出） |
628 |
$4.31 |
$2.71K |
323,826 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
